NCT05703958

Brief Summary

The objective of this study is to collect and evaluate long-term clinical outcomes data in order to better understand the safety and performance of the Equinoxe Proximal Humerus Fracture Plates over time. This study will follow subjects for a period of up to 10 years post-surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
151

participants targeted

Target at P50-P75 for all trials

Timeline
102mo left

Started Apr 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Apr 2023Sep 2034

First Submitted

Initial submission to the registry

January 19, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 30, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

April 19, 2023

Completed
10.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2033

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2034

Last Updated

October 24, 2024

Status Verified

October 1, 2024

Enrollment Period

10.7 years

First QC Date

January 19, 2023

Last Update Submit

October 23, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Smart Score

    Shoulder Arthroplasty Smart (SAS) score - 6 questions based on 3 objective active range of motion and 3 subjective measures of pain and function. Score range of 0 to 100 where 100 indicates the best score

    Through study completion, an average of 1 per year

  • Sane Score

    Single Assessment Numeric Evaluation (SANE) - Patient shoulder self-evaluation as a percentage of normal, 100% corresponds being normal

    Through study completion, an average of 1 per year

  • ASES

    American Shoulder and Elbow Surgeons Score (ASES) - 100 points scale about shoulder pain and performance evaluation in activities of daily living where 100 indicates the best shoulder condition

    Through study completion, an average of 1 per year

  • Quick DASH

    Shorten version of Disability of the Arm, Shoulder, and Hand (DASH) - 11 items to measure ability of a patient to perform certain upper extremity where 0 corresponds to no difficulty and 100 corresponds to unable

    Through study completion, an average of 1 per year

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing ORIF surgery who meet eligibility criteria - Patients who consent to participate to return for follow-up visits out to 10 years or longer

You may qualify if:

  • Patient is indicated to receive Equinoxe Proximal Humerus Fracture Plate or has previously underwent primary surgery with Equioxe Proximal Humerus Fracture Plate
  • Patient is willing to participate by complying with pre- and postoperative visit requirements
  • Patient is willing to agree to be followed for up to 10 years following their index surgery
  • Patient is willing and able to review and sign a study informed consent form

You may not qualify if:

  • Osteomyelitis of the proximal humerus or scapula
  • Inadequate or malformed bone that precludes adequate support or fixation of the prosthesis
  • Patient's age, weight, or activity level would cause the surgeon to expect early failure of the system
  • The patient is unwilling or unable to comply with the post-operative care instructions
  • Alcohol, drug, or other subtance abuse
  • Any disease state that could adversaly affect the function or longevity of the implant
  • Patient is pregnant
  • Patient is a prisoner
  • Patient has a physical or mental condition that would invalidate the results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Grossman School of Medicine

New York, New York, 10016, United States

RECRUITING

MeSH Terms

Conditions

Shoulder FracturesFracture DislocationFractures, Ununited

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesShoulder InjuriesJoint DislocationsJoint DiseasesMusculoskeletal Diseases

Study Officials

  • Abhishek Ganta, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2023

First Posted

January 30, 2023

Study Start

April 19, 2023

Primary Completion (Estimated)

December 31, 2033

Study Completion (Estimated)

September 30, 2034

Last Updated

October 24, 2024

Record last verified: 2024-10

Locations